Cargando…
Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial
BACKGROUND: Current guidelines for the diagnosis and management of patients with stable coronary artery disease (CAD) recommend functional stress testing for risk stratification prior to revascularization procedures. Cardiac magnetic resonance imaging (CMR) is a modality of choice for stress testing...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534045/ https://www.ncbi.nlm.nih.gov/pubmed/28754155 http://dx.doi.org/10.1186/s13063-017-2101-6 |
_version_ | 1783253713600643072 |
---|---|
author | Buckert, Dominik Witzel, Simon Cieslik, Maciej Tibi, Raid Rottbauer, Wolfgang Bernhardt, Peter |
author_facet | Buckert, Dominik Witzel, Simon Cieslik, Maciej Tibi, Raid Rottbauer, Wolfgang Bernhardt, Peter |
author_sort | Buckert, Dominik |
collection | PubMed |
description | BACKGROUND: Current guidelines for the diagnosis and management of patients with stable coronary artery disease (CAD) recommend functional stress testing for risk stratification prior to revascularization procedures. Cardiac magnetic resonance imaging (CMR) is a modality of choice for stress testing because of its capability to detect myocardial ischemia sensitively and specifically. Nevertheless, evidence from randomized trials evaluating a CMR-based management of stable CAD patients in comparison to a more common angiography-based approach still is limited. METHODS/DESIGN: Patients presenting themselves with symptoms indicating a stable CAD and a class I or IIa indication for diagnostic coronary angiography are prospectively screened and enrolled in the study. All subjects receive a basic cardiological work-up and guideline-directed medical therapy. A 1:1 randomization in two groups is being performed. Patients in group 1 undergo diagnostic coronary angiography and subsequent revascularization according to current guidelines. Subjects in group 2 undergo adenosine stress CMR and in case of myocardial ischemia are sent to coronary angiography. Follow-up is planned for 3 years. During this time, the number of primary endpoints (defined as cardiac death and non-fatal myocardial infarction) and unplanned invasive procedures will be documented. Furthermore, symptom burden and quality of life will be assessed by use of the Seattle Angina Questionnaire. Sample size is calculated to prove non-inferiority of the CMR-based approach. DISCUSSION: In case this study is able to accomplish its aim to prove non-inferiority of the CMR-based management in patients with stable CAD; the importance of this emerging modality may further increase. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02580851. Registered on 14 October 2015. Unique Protocol ID: 237/11 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-017-2101-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5534045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55340452017-08-03 Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial Buckert, Dominik Witzel, Simon Cieslik, Maciej Tibi, Raid Rottbauer, Wolfgang Bernhardt, Peter Trials Study Protocol BACKGROUND: Current guidelines for the diagnosis and management of patients with stable coronary artery disease (CAD) recommend functional stress testing for risk stratification prior to revascularization procedures. Cardiac magnetic resonance imaging (CMR) is a modality of choice for stress testing because of its capability to detect myocardial ischemia sensitively and specifically. Nevertheless, evidence from randomized trials evaluating a CMR-based management of stable CAD patients in comparison to a more common angiography-based approach still is limited. METHODS/DESIGN: Patients presenting themselves with symptoms indicating a stable CAD and a class I or IIa indication for diagnostic coronary angiography are prospectively screened and enrolled in the study. All subjects receive a basic cardiological work-up and guideline-directed medical therapy. A 1:1 randomization in two groups is being performed. Patients in group 1 undergo diagnostic coronary angiography and subsequent revascularization according to current guidelines. Subjects in group 2 undergo adenosine stress CMR and in case of myocardial ischemia are sent to coronary angiography. Follow-up is planned for 3 years. During this time, the number of primary endpoints (defined as cardiac death and non-fatal myocardial infarction) and unplanned invasive procedures will be documented. Furthermore, symptom burden and quality of life will be assessed by use of the Seattle Angina Questionnaire. Sample size is calculated to prove non-inferiority of the CMR-based approach. DISCUSSION: In case this study is able to accomplish its aim to prove non-inferiority of the CMR-based management in patients with stable CAD; the importance of this emerging modality may further increase. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02580851. Registered on 14 October 2015. Unique Protocol ID: 237/11 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-017-2101-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-28 /pmc/articles/PMC5534045/ /pubmed/28754155 http://dx.doi.org/10.1186/s13063-017-2101-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Buckert, Dominik Witzel, Simon Cieslik, Maciej Tibi, Raid Rottbauer, Wolfgang Bernhardt, Peter Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial |
title | Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial |
title_full | Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial |
title_fullStr | Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial |
title_full_unstemmed | Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial |
title_short | Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial |
title_sort | magnetic resonance adenosine perfusion imaging as gatekeeper of invasive coronary intervention (magnet): study protocol for a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534045/ https://www.ncbi.nlm.nih.gov/pubmed/28754155 http://dx.doi.org/10.1186/s13063-017-2101-6 |
work_keys_str_mv | AT buckertdominik magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial AT witzelsimon magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial AT cieslikmaciej magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial AT tibiraid magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial AT rottbauerwolfgang magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial AT bernhardtpeter magneticresonanceadenosineperfusionimagingasgatekeeperofinvasivecoronaryinterventionmagnetstudyprotocolforarandomizedcontrolledtrial |